Latest publications
-
Estimating the disease burden of respiratory syncytial virus (RSV) in older adults in England during the 2023/24 season: a new national hospital-based surveillance system
Symes R. et al, (2025)
-
Activity-based protein profiling reveals both canonical and novel ubiquitin pathway enzymes in Plasmodium
Smith C. et al, (2025), PLOS Pathogens, 21, e1013032 - e1013032
-
Pleural fluid proteomics from patients with pleural infection shows signatures of diverse neutrophilic responses: The Oxford Pleural Infection Endotyping Study (TORPIDS-2).
Kanellakis NI. et al, (2025), Eur Respir J
-
Perturbing LSD1 and WNT rewires transcription to synergistically induce AML differentiation
Hosseini A. et al, (2025), Nature
-
Effect of a Laparoscopic Donor Nephrectomy as an Intermediate Surgical Procedure on the Acute Phase Response in Healthy Living Kidney Donors Using Either Propofol or Sevoflurane Anaesthesia
Brattinga B. et al, (2025)
COI Affiliated Publications (First author/ Corresponding author)
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15
AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein-specific Th1 response with a diverse TCR repertoire
Swanson PA. et al, (2021), Science Translational Medicine
DUB esterase activity further decodes ubiquitin’s enigma
Kessler BM., (2021), Proceedings of the National Academy of Sciences, 118, e2026389118 - e2026389118
COI Affiliated Publications (non-first author/ corresponding author)
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
Stuart ASV. et al, (2022), Lancet (London, England), 399, 36 - 49
Pleural Fluid Has Pro-Growth Biological Properties Which Enable Cancer Cell Proliferation
Asciak R. et al, (2021), Frontiers in Oncology, 11